Vivovec™ Surface-Engineered Lentiviral Particles Mediate In Vivo CAR T Generation with Potent and Highly Durable Activity in Non-Human Primates and Tumor-Bearing Humanized MiceMaura H. Parker, Byoung Y. Ryu, Don Parrilla et al.|Blood|2023Cited by 7
Abstract 547: Generation of synthetic cytokine receptor-induced cytotoxic innate lymphocytes (iCILs) from iPSCs as off-the-shelf cancer therapeuticsSamantha O'Hara, Ryan Larson, Teisha J. Rowland et al.|Cancer Research|2022Cited by 0
1230 VivoVec lentiviral vector particles surface-engineered with T cell activating and co-stimulatory ligands enhance<i>in vivo</i>CAR T cell generation and antitumor activityChris Nicolai, Wai‐Hang Leung, Jim Qin et al.|Regular and Young Investigator Award Abstracts|2022Cited by 0